Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
323 | 3649 | 28.1 | 73% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
21 | 4 | UROLOGY & NEPHROLOGY//UROL//JOURNAL OF UROLOGY | 229838 |
450 | 3 | BLADDER CANCER//CYSTECTOMY//BLADDER NEOPLASMS | 25609 |
298 | 2 | BLADDER CANCER//CYSTECTOMY//BLADDER NEOPLASMS | 18621 |
323 | 1 | NON MUSCLE INVASIVE BLADDER CANCER//SUPERFICIAL BLADDER CANCER//BACILLUS CALMETTE GUERIN | 3649 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | NON MUSCLE INVASIVE BLADDER CANCER | authKW | 929598 | 4% | 71% | 156 |
2 | SUPERFICIAL BLADDER CANCER | authKW | 864921 | 4% | 70% | 147 |
3 | BACILLUS CALMETTE GUERIN | authKW | 857884 | 5% | 51% | 200 |
4 | BLADDER NEOPLASMS | authKW | 717939 | 10% | 23% | 373 |
5 | BLADDER CANCER | authKW | 566536 | 18% | 10% | 667 |
6 | INTRAVESICAL CHEMOTHERAPY | authKW | 559652 | 2% | 79% | 85 |
7 | INTRAVESICAL THERAPY | authKW | 520663 | 3% | 66% | 95 |
8 | BCG | authKW | 433496 | 7% | 21% | 244 |
9 | BCG VACCINE | authKW | 429341 | 4% | 38% | 135 |
10 | FLUORESCENCE CYSTOSCOPY | authKW | 240934 | 1% | 80% | 36 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Urology & Nephrology | 179833 | 64% | 1% | 2344 |
2 | Oncology | 3708 | 18% | 0% | 660 |
3 | Pathology | 608 | 4% | 0% | 158 |
4 | Medicine, General & Internal | 55 | 4% | 0% | 133 |
5 | Immunology | 13 | 3% | 0% | 108 |
6 | Rheumatology | 13 | 1% | 0% | 24 |
7 | Medicine, Research & Experimental | 9 | 2% | 0% | 68 |
8 | Pharmacology & Pharmacy | 6 | 4% | 0% | 136 |
9 | Infectious Diseases | 2 | 1% | 0% | 39 |
10 | Dermatology | 1 | 1% | 0% | 25 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UROL | 170442 | 41% | 1% | 1494 |
2 | BCG ONCOL | 43025 | 0% | 86% | 6 |
3 | FUNDACIO PUIGVERT | 39230 | 1% | 17% | 28 |
4 | DEF MED BUR | 25099 | 0% | 100% | 3 |
5 | SERV UROL | 19050 | 3% | 2% | 102 |
6 | BACTERIAL INFECT ANTIMICROBIAL THER Y GRP | 16733 | 0% | 100% | 2 |
7 | IMMUNOLCEDOC | 16733 | 0% | 100% | 2 |
8 | MOL BIOTECHNOL 4 | 16733 | 0% | 100% | 2 |
9 | ONCOL RECONSTRUCT UROL | 16733 | 0% | 100% | 2 |
10 | ONCOUROL GRP | 16733 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF UROLOGY | 99016 | 16% | 2% | 573 |
2 | EUROPEAN UROLOGY | 87137 | 8% | 4% | 274 |
3 | BJU INTERNATIONAL | 34314 | 5% | 2% | 183 |
4 | UROLOGY | 24010 | 6% | 1% | 217 |
5 | UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 19165 | 2% | 3% | 66 |
6 | PROGRES EN UROLOGIE | 18761 | 2% | 3% | 86 |
7 | BRITISH JOURNAL OF UROLOGY | 17947 | 3% | 2% | 114 |
8 | EUROPEAN UROLOGY SUPPLEMENTS | 17423 | 1% | 6% | 35 |
9 | UROLOGIA INTERNATIONALIS | 14724 | 2% | 2% | 90 |
10 | WORLD JOURNAL OF UROLOGY | 14660 | 2% | 2% | 73 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NON MUSCLE INVASIVE BLADDER CANCER | 929598 | 4% | 71% | 156 | Search NON+MUSCLE+INVASIVE+BLADDER+CANCER | Search NON+MUSCLE+INVASIVE+BLADDER+CANCER |
2 | SUPERFICIAL BLADDER CANCER | 864921 | 4% | 70% | 147 | Search SUPERFICIAL+BLADDER+CANCER | Search SUPERFICIAL+BLADDER+CANCER |
3 | BACILLUS CALMETTE GUERIN | 857884 | 5% | 51% | 200 | Search BACILLUS+CALMETTE+GUERIN | Search BACILLUS+CALMETTE+GUERIN |
4 | BLADDER NEOPLASMS | 717939 | 10% | 23% | 373 | Search BLADDER+NEOPLASMS | Search BLADDER+NEOPLASMS |
5 | BLADDER CANCER | 566536 | 18% | 10% | 667 | Search BLADDER+CANCER | Search BLADDER+CANCER |
6 | INTRAVESICAL CHEMOTHERAPY | 559652 | 2% | 79% | 85 | Search INTRAVESICAL+CHEMOTHERAPY | Search INTRAVESICAL+CHEMOTHERAPY |
7 | INTRAVESICAL THERAPY | 520663 | 3% | 66% | 95 | Search INTRAVESICAL+THERAPY | Search INTRAVESICAL+THERAPY |
8 | BCG | 433496 | 7% | 21% | 244 | Search BCG | Search BCG |
9 | BCG VACCINE | 429341 | 4% | 38% | 135 | Search BCG+VACCINE | Search BCG+VACCINE |
10 | FLUORESCENCE CYSTOSCOPY | 240934 | 1% | 80% | 36 | Search FLUORESCENCE+CYSTOSCOPY | Search FLUORESCENCE+CYSTOSCOPY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BABJUK, M , BURGER, M , ZIGEUNER, R , SHARIAT, SF , VAN RHIJN, BWG , COMPERAT, E , SYLVESTER, RJ , KAASINEN, E , BOHLE, A , REDORTA, JP , ET AL (2013) EAU GUIDELINES ON NON-MUSCLE-INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER: UPDATE 2013.EUROPEAN UROLOGY. VOL. 64. ISSUE 4. P. 639-653 | 79 | 79% | 377 |
2 | ASIN, MAPJ , FERNANDEZ-RUIZ, M , LOPEZ-MEDRANO, F , LUMBRERAS, C , TEJIDO, A , SAN JUAN, R , ARREBOLA-PAJARES, A , LIZASOAIN, M , PRIETO, S , AGUADO, JM , (2014) BACILLUS CALMETTE-GUERIN (BCG) INFECTION FOLLOWING INTRAVESICAL BCG ADMINISTRATION AS ADJUNCTIVE THERAPY FOR BLADDER CANCER INCIDENCE, RISK FACTORS, AND OUTCOME IN A SINGLE-INSTITUTION SERIES AND REVIEW OF THE LITERATURE.MEDICINE. VOL. 93. ISSUE 17. P. 236 -254 | 122 | 88% | 9 |
3 | VAN RHIJN, BWG , BURGER, M , LOTAN, Y , SOLSONA, E , STIEF, CG , SYLVESTER, RJ , WITJES, JA , ZLOTTA, AR , (2009) RECURRENCE AND PROGRESSION OF DISEASE IN NON-MUSCLE-INVASIVE BLADDER CANCER: FROM EPIDEMIOLOGY TO TREATMENT STRATEGY.EUROPEAN UROLOGY. VOL. 56. ISSUE 3. P. 430-442 | 105 | 81% | 197 |
4 | REDELMAN-SIDI, G , GLICKMAN, MS , BOCHNER, BH , (2014) THE MECHANISM OF ACTION OF BCG THERAPY FOR BLADDER CANCER-A CURRENT PERSPECTIVE.NATURE REVIEWS UROLOGY. VOL. 11. ISSUE 3. P. 153 -162 | 90 | 87% | 49 |
5 | KASSOUF, W , TRABOULSI, SL , KULKARNI, GS , BREAU, RH , ZLOTTA, A , FAIREY, A , SO, A , LACOMBE, L , RENDON, R , APRIKIAN, AG , ET AL (2015) CUA GUIDELINES ON THE MANAGEMENT OF NON-MUSCLE INVASIVE BLADDER CANCER.CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL. VOL. 9. ISSUE 9-10. P. E690 -E704 | 121 | 79% | 1 |
6 | PATEL, SG , COHEN, A , WEINER, AB , STEINBERG, GD , (2015) INTRAVESICAL THERAPY FOR BLADDER CANCER.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 16. ISSUE 6. P. 889 -901 | 89 | 89% | 7 |
7 | ALDOUSARI, S , KASSOUF, W , (2010) UPDATE ON THE MANAGEMENT OF NON-MUSCLE INVASIVE BLADDER CANCER.CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL. VOL. 4. ISSUE 1. P. 56-64 | 107 | 90% | 10 |
8 | VAN LINGEN, AV , WITJES, JA , (2013) CURRENT INTRAVESICAL THERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER.EXPERT OPINION ON BIOLOGICAL THERAPY. VOL. 13. ISSUE 10. P. 1371 -1385 | 94 | 91% | 8 |
9 | MITROPOULOS, DN , (2005) NOVEL INSIGHTS INTO THE MECHANISM OF ACTION OF INTRAVESICAL IMMUNOMODULATORS.IN VIVO. VOL. 19. ISSUE 3. P. 611 -621 | 129 | 81% | 15 |
10 | LEOPARDO, D , CECERE, SC , DI NAPOLI, M , CAVALIERE, C , PISANO, C , STRIANO, S , MARRA, L , MENNA, L , CLAUDIO, L , PERDONA, S , ET AL (2013) INTRAVESICAL CHEMO-IMMUNOTHERAPY IN NON MUSCLE INVASIVE BLADDER CANCER.EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES. VOL. 17. ISSUE 16. P. 2145-2158 | 88 | 94% | 5 |
Classes with closest relation at Level 1 |